Putative activation of the peroxisome proliferator-activated receptor γ impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells

P. D. Schoppee, J. C. Garmey, Johannes D Veldhuis

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Ovarian theca cells are the predominant source of gonadotropin-stimulated androgen biosynthesis in vivo. Troglitazone (TG), a synthetic agonist of the peroxisome proliferator-activated receptor γ (PPARγ) and a thiazolidinedione used to treat insulin resistance, decreases serum androgen concentrations in women with hyperthecosis and/or polycystic ovary syndrome. Using reverse transcription-polymerase chain reaction (RT-PCR), we demonstrated the presence of PPARγ mRNA in the porcine ovary. Since activation of ovarian PPARγ may alter hormone-stimulated steroidogenesis in vitro, we cultured porcine theca cells for 48 h in the presence of two different PPARγ ligands, TG and 15-deoxy-Δ-prostaglandin J2 (15d-PGJ2). Putative TG-mediated activation of PPARγ resulted in a 53%-69% decrease in LH- and/or insulin-stimulated androstenedione and testosterone accumulation. Although TG reduced 3-isobutylmethylxanthine-enhanced LH-stimulated cAMP accumulation by 74%-78%, it did not alter basal cAMP concentrations. Exposure to 8Br-cAMP did not overcome the TG-induced inhibition of androgen accumulation. In contrast, TG administration amplified basal and hormone-stimulated progesterone accumulation, parcticularly in the presence of insulin, without altering levels of 17α-hydroxyprogesterone. The putative natural PPARγ ligand, 15d-PGJ2, inhibited androgen biosynthesis and stimulated progesterone production. RT-PCR-based amplification of cytochrome P450 cholesterol side-chain cleavage (CYP11A) and cytochrome P450 17α-hydroxylase/C-17,20-lyase (CYP17) transcripts indicated that TG moderately enhanced expression of these genes. However, TG did not affect CYP17 protein expression. We conclude that putative ligand-mediated activation of PPARγ decreases LH- and/or insulin-driven theca cell androgen production by impairing the ability of CYP17 to synthesize androstenedione from available progestins. The corresponding augmentation of progesterone production could suggest that PPARγ activation induces theca cell differentiation toward a progestinsynthesizing phenotype.

Original languageEnglish (US)
Pages (from-to)190-198
Number of pages9
JournalBiology of Reproduction
Volume66
Issue number1
StatePublished - 2002
Externally publishedYes

Fingerprint

troglitazone
Theca Cells
Peroxisome Proliferator-Activated Receptors
Androgens
Progesterone
Swine
Steroid 17-alpha-Hydroxylase
Androstenedione
Insulin
Ligands
Cytochrome P-450 Enzyme System
Reverse Transcription
Hormones
17-alpha-Hydroxyprogesterone
Polymerase Chain Reaction
Polycystic Ovary Syndrome
Progestins
Mixed Function Oxygenases
Gonadotropins
Insulin Resistance

Keywords

  • Gene regulation
  • Mechanisms of hormone action
  • Ovary
  • Steroid hormones
  • Theca cells

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Embryology

Cite this

Putative activation of the peroxisome proliferator-activated receptor γ impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. / Schoppee, P. D.; Garmey, J. C.; Veldhuis, Johannes D.

In: Biology of Reproduction, Vol. 66, No. 1, 2002, p. 190-198.

Research output: Contribution to journalArticle

@article{af5e5b71fc284da8b3e7583dc7cdabca,
title = "Putative activation of the peroxisome proliferator-activated receptor γ impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells",
abstract = "Ovarian theca cells are the predominant source of gonadotropin-stimulated androgen biosynthesis in vivo. Troglitazone (TG), a synthetic agonist of the peroxisome proliferator-activated receptor γ (PPARγ) and a thiazolidinedione used to treat insulin resistance, decreases serum androgen concentrations in women with hyperthecosis and/or polycystic ovary syndrome. Using reverse transcription-polymerase chain reaction (RT-PCR), we demonstrated the presence of PPARγ mRNA in the porcine ovary. Since activation of ovarian PPARγ may alter hormone-stimulated steroidogenesis in vitro, we cultured porcine theca cells for 48 h in the presence of two different PPARγ ligands, TG and 15-deoxy-Δ-prostaglandin J2 (15d-PGJ2). Putative TG-mediated activation of PPARγ resulted in a 53{\%}-69{\%} decrease in LH- and/or insulin-stimulated androstenedione and testosterone accumulation. Although TG reduced 3-isobutylmethylxanthine-enhanced LH-stimulated cAMP accumulation by 74{\%}-78{\%}, it did not alter basal cAMP concentrations. Exposure to 8Br-cAMP did not overcome the TG-induced inhibition of androgen accumulation. In contrast, TG administration amplified basal and hormone-stimulated progesterone accumulation, parcticularly in the presence of insulin, without altering levels of 17α-hydroxyprogesterone. The putative natural PPARγ ligand, 15d-PGJ2, inhibited androgen biosynthesis and stimulated progesterone production. RT-PCR-based amplification of cytochrome P450 cholesterol side-chain cleavage (CYP11A) and cytochrome P450 17α-hydroxylase/C-17,20-lyase (CYP17) transcripts indicated that TG moderately enhanced expression of these genes. However, TG did not affect CYP17 protein expression. We conclude that putative ligand-mediated activation of PPARγ decreases LH- and/or insulin-driven theca cell androgen production by impairing the ability of CYP17 to synthesize androstenedione from available progestins. The corresponding augmentation of progesterone production could suggest that PPARγ activation induces theca cell differentiation toward a progestinsynthesizing phenotype.",
keywords = "Gene regulation, Mechanisms of hormone action, Ovary, Steroid hormones, Theca cells",
author = "Schoppee, {P. D.} and Garmey, {J. C.} and Veldhuis, {Johannes D}",
year = "2002",
language = "English (US)",
volume = "66",
pages = "190--198",
journal = "Biology of Reproduction",
issn = "0006-3363",
publisher = "Society for the Study of Reproduction",
number = "1",

}

TY - JOUR

T1 - Putative activation of the peroxisome proliferator-activated receptor γ impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells

AU - Schoppee, P. D.

AU - Garmey, J. C.

AU - Veldhuis, Johannes D

PY - 2002

Y1 - 2002

N2 - Ovarian theca cells are the predominant source of gonadotropin-stimulated androgen biosynthesis in vivo. Troglitazone (TG), a synthetic agonist of the peroxisome proliferator-activated receptor γ (PPARγ) and a thiazolidinedione used to treat insulin resistance, decreases serum androgen concentrations in women with hyperthecosis and/or polycystic ovary syndrome. Using reverse transcription-polymerase chain reaction (RT-PCR), we demonstrated the presence of PPARγ mRNA in the porcine ovary. Since activation of ovarian PPARγ may alter hormone-stimulated steroidogenesis in vitro, we cultured porcine theca cells for 48 h in the presence of two different PPARγ ligands, TG and 15-deoxy-Δ-prostaglandin J2 (15d-PGJ2). Putative TG-mediated activation of PPARγ resulted in a 53%-69% decrease in LH- and/or insulin-stimulated androstenedione and testosterone accumulation. Although TG reduced 3-isobutylmethylxanthine-enhanced LH-stimulated cAMP accumulation by 74%-78%, it did not alter basal cAMP concentrations. Exposure to 8Br-cAMP did not overcome the TG-induced inhibition of androgen accumulation. In contrast, TG administration amplified basal and hormone-stimulated progesterone accumulation, parcticularly in the presence of insulin, without altering levels of 17α-hydroxyprogesterone. The putative natural PPARγ ligand, 15d-PGJ2, inhibited androgen biosynthesis and stimulated progesterone production. RT-PCR-based amplification of cytochrome P450 cholesterol side-chain cleavage (CYP11A) and cytochrome P450 17α-hydroxylase/C-17,20-lyase (CYP17) transcripts indicated that TG moderately enhanced expression of these genes. However, TG did not affect CYP17 protein expression. We conclude that putative ligand-mediated activation of PPARγ decreases LH- and/or insulin-driven theca cell androgen production by impairing the ability of CYP17 to synthesize androstenedione from available progestins. The corresponding augmentation of progesterone production could suggest that PPARγ activation induces theca cell differentiation toward a progestinsynthesizing phenotype.

AB - Ovarian theca cells are the predominant source of gonadotropin-stimulated androgen biosynthesis in vivo. Troglitazone (TG), a synthetic agonist of the peroxisome proliferator-activated receptor γ (PPARγ) and a thiazolidinedione used to treat insulin resistance, decreases serum androgen concentrations in women with hyperthecosis and/or polycystic ovary syndrome. Using reverse transcription-polymerase chain reaction (RT-PCR), we demonstrated the presence of PPARγ mRNA in the porcine ovary. Since activation of ovarian PPARγ may alter hormone-stimulated steroidogenesis in vitro, we cultured porcine theca cells for 48 h in the presence of two different PPARγ ligands, TG and 15-deoxy-Δ-prostaglandin J2 (15d-PGJ2). Putative TG-mediated activation of PPARγ resulted in a 53%-69% decrease in LH- and/or insulin-stimulated androstenedione and testosterone accumulation. Although TG reduced 3-isobutylmethylxanthine-enhanced LH-stimulated cAMP accumulation by 74%-78%, it did not alter basal cAMP concentrations. Exposure to 8Br-cAMP did not overcome the TG-induced inhibition of androgen accumulation. In contrast, TG administration amplified basal and hormone-stimulated progesterone accumulation, parcticularly in the presence of insulin, without altering levels of 17α-hydroxyprogesterone. The putative natural PPARγ ligand, 15d-PGJ2, inhibited androgen biosynthesis and stimulated progesterone production. RT-PCR-based amplification of cytochrome P450 cholesterol side-chain cleavage (CYP11A) and cytochrome P450 17α-hydroxylase/C-17,20-lyase (CYP17) transcripts indicated that TG moderately enhanced expression of these genes. However, TG did not affect CYP17 protein expression. We conclude that putative ligand-mediated activation of PPARγ decreases LH- and/or insulin-driven theca cell androgen production by impairing the ability of CYP17 to synthesize androstenedione from available progestins. The corresponding augmentation of progesterone production could suggest that PPARγ activation induces theca cell differentiation toward a progestinsynthesizing phenotype.

KW - Gene regulation

KW - Mechanisms of hormone action

KW - Ovary

KW - Steroid hormones

KW - Theca cells

UR - http://www.scopus.com/inward/record.url?scp=0036136904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036136904&partnerID=8YFLogxK

M3 - Article

C2 - 11751282

AN - SCOPUS:0036136904

VL - 66

SP - 190

EP - 198

JO - Biology of Reproduction

JF - Biology of Reproduction

SN - 0006-3363

IS - 1

ER -